Ramkumar Mandalam, a director at $CYRX ($CYRX), sold 7,369 shares of the company on 12-02-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 11.0% of their shares....
JERRELL SHELTON, the President of $CYRX ($CYRX), sold 22,817 shares of the company on 11-22-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.0% of their...
JERRELL SHELTON, the President of $CYRX ($CYRX), sold 50,000 shares of the company on 11-19-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 6.6% of their...
/PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative products and services to the fast-growing...
/PRNewswire/ -- Be The Match BioTherapies®, an organization offering solutions for companies developing and commercializing cell and gene therapies, and...
/PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative products and services to the fast-growing...
/PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative products and services to the fast-growing...
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cryoport, Inc. ("Cryoport" or the "Company") (NASDAQ: CYRX). Such investors are...
/PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative products and services for the fast growing...
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cryoport, Inc. ("Cryoport" or the "Company") (NASDAQ: CYRX). Such investors are...